Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Biggs

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Transplantation|November 1, 1983
The chemical and immunosuppressive stability of cyclosporine during continuous intravenous infusionK Atkinson, K Britton, C Farrell, et al.
Leukemia Research|January 1, 1987
Donor marrow progenitors (CFU-Mix, BFU-E and CFU-GM) and haemopoietic engraftment following HLA matched sibling bone marrow transplantationD D Ma, D E Varga, J C Biggs
American Journal of Clinical Pathology|May 1, 1980
A fatal case of cold autoimmune hemolytic anemiaM Seldon, J P Isbister, E Raik, et al.
Australian and New Zealand Journal of Medicine|April 1, 1993
Clinical analysis of 125 patients with the lupus anticoagulantM Morgan, K Downs, C N Chesterman, et al.
Immunology and Cell Biology|June 1, 1997
A recombinant GM-CSF-PE40 ligand toxin is functionally active but not cytotoxic to cellsP O'Brien, A Smythe, J C Biggs, et al.
Experimental Hematology|August 1, 1995
Improved specificity of ribozyme-mediated cleavage of bcr-abl mRNAP Kearney, L A Wright, S Milliken, et al.
Transplantation Proceedings|April 1, 1986
Peripheral blood mononuclear cells (PBMC) from recipients of human bone marrow allografts suppress mitogen-induced proliferation of marrow donor PBMCM A Cooley, G Chapman, K Atkinson, et al.
Transplantation Proceedings|February 1, 1989
Can morbidity and mortality of matched allogeneic marrow grafts be reduced?J C Biggs, K Atkinson, A J Dodds, et al.
Antisense & Nucleic Acid Drug Development|March 25, 1998
Ex vivo effects associated with the expression of a bcr-abl-specific ribozyme in a CML cell lineL A Wright, S Milliken, J C Biggs, et al.
Stem Cells (Dayton, Ohio)|November 10, 2000
Sensitivity of c-erbB positive cells to a ligand toxin and its utility in purging breast cancer cells from peripheral blood stem cell (PBSC) collectionsM Keir, R Fiddes, J C Biggs, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Transplantation|November 1, 1983
The chemical and immunosuppressive stability of cyclosporine during continuous intravenous infusionK Atkinson, K Britton, C Farrell, et al.
Leukemia Research|January 1, 1987
Donor marrow progenitors (CFU-Mix, BFU-E and CFU-GM) and haemopoietic engraftment following HLA matched sibling bone marrow transplantationD D Ma, D E Varga, J C Biggs
American Journal of Clinical Pathology|May 1, 1980
A fatal case of cold autoimmune hemolytic anemiaM Seldon, J P Isbister, E Raik, et al.
Australian and New Zealand Journal of Medicine|April 1, 1993
Clinical analysis of 125 patients with the lupus anticoagulantM Morgan, K Downs, C N Chesterman, et al.
Immunology and Cell Biology|June 1, 1997
A recombinant GM-CSF-PE40 ligand toxin is functionally active but not cytotoxic to cellsP O'Brien, A Smythe, J C Biggs, et al.
Experimental Hematology|August 1, 1995
Improved specificity of ribozyme-mediated cleavage of bcr-abl mRNAP Kearney, L A Wright, S Milliken, et al.
Transplantation Proceedings|April 1, 1986
Peripheral blood mononuclear cells (PBMC) from recipients of human bone marrow allografts suppress mitogen-induced proliferation of marrow donor PBMCM A Cooley, G Chapman, K Atkinson, et al.
Transplantation Proceedings|February 1, 1989
Can morbidity and mortality of matched allogeneic marrow grafts be reduced?J C Biggs, K Atkinson, A J Dodds, et al.
Antisense & Nucleic Acid Drug Development|March 25, 1998
Ex vivo effects associated with the expression of a bcr-abl-specific ribozyme in a CML cell lineL A Wright, S Milliken, J C Biggs, et al.
Stem Cells (Dayton, Ohio)|November 10, 2000
Sensitivity of c-erbB positive cells to a ligand toxin and its utility in purging breast cancer cells from peripheral blood stem cell (PBSC) collectionsM Keir, R Fiddes, J C Biggs, et al.
Pageof 12